Literature DB >> 2033314

The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.

A Dabrowski1, A Gabryelewicz, L Chyczewski.   

Abstract

Acute edematous pancreatitis was induced in Wistar male rats by iv infusion of cerulein (CR) in the dose of 5.10(-6)g.kg-1.h-1 during 3 or 6 h. The effect of BN 52021--platelet activating factor (PAF) receptor antagonist, against this model of disease was examined. BN 52021 was applied iv as a bolus injection in the dose of 5.10(-3)g.kg-1 at 0 time. Treatment with this agent significantly ameliorates cerulein-induced acute pancreatitis in rats. The effect of BN 52021 was expressed by significant reduction of pancreas edema, diminution of hyperamylasemia, lack of superoxide dismutase activity depletion, and inhibition of lipid peroxidation in pancreatic tissue. These changes were accompanied by significant reduction of acinar cells vacuolization and remarkable inhibition of infiltration with inflammatory cells in the interacinar space. We suppose that beneficial effect of BN 52021 against cerulein-induced acute pancreatitis in rats depends on the prevention of inflammatory cells activation and subsequent generation of oxygen radicals within pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033314     DOI: 10.1007/bf02930218

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  29 in total

1.  A stable starch substrate for the determination of amylase in serum and other body fluids.

Authors:  W T CARAWAY
Journal:  Am J Clin Pathol       Date:  1959-07       Impact factor: 2.493

2.  Hydroperoxide metabolism in mammalian organs.

Authors:  B Chance; H Sies; A Boveris
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

3.  Malondialdehyde formation as an indicator of prostaglandin production by human platelets.

Authors:  J B Smith; C M Ingerman; M J Silver
Journal:  J Lab Clin Med       Date:  1976-07

4.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

Review 5.  Lipid peroxidation and cellular damage in toxic liver injury.

Authors:  M Comporti
Journal:  Lab Invest       Date:  1985-12       Impact factor: 5.662

6.  The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.

Authors:  H P Misra; I Fridovich
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

7.  Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

Authors:  C Niederau; L D Ferrell; J H Grendell
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

8.  The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models.

Authors:  H Sanfey; G B Bulkley; J L Cameron
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

9.  When should treatment of acute experimental pancreatitis be started? The early phase of bile-induced acute pancreatitis.

Authors:  P G Lankisch; U Pohl; J Otto; G Rahlf
Journal:  Res Exp Med (Berl)       Date:  1988

Review 10.  Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation.

Authors:  H Kappus; H Sies
Journal:  Experientia       Date:  1981-12-15
View more
  10 in total

1.  Current views on the pathophysiology of acute biliary pancreatitis.

Authors:  A K Banerjee; R J Steele
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 2.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  Drug Therapy for Acute Pancreatitis.

Authors:  Yan Bi; Tegpal Atwal; Santhi Swaroop Vege
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

4.  The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.

Authors:  A Dabrowski; A Gabryelewicz; L Chyczewski
Journal:  Int J Pancreatol       Date:  1995-04

5.  Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.

Authors:  W Zhou; B A Levine; M S Olson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 6.  Role of platelet-activating factor in the pathogenesis of acute pancreatitis.

Authors:  Li-Rong Liu; Shi-Hai Xia
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 7.  Pharmacological approach to acute pancreatitis.

Authors:  Ulrich-Christian Bang; Synne Semb; Camilla Nojgaard; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

8.  Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.

Authors:  U Leonhardt; A Fayyazzi; F Seidensticker; F Stöckmann; H D Söling; W Creutzfeldt
Journal:  Int J Pancreatol       Date:  1992-10

9.  Evidence for early oxidative stress in acute pancreatitis. Clues for correction.

Authors:  J M Braganza; P Scott; D Bilton; D Schofield; C Chaloner; N Shiel; L P Hunt; T Bottiglieri
Journal:  Int J Pancreatol       Date:  1995-02

10.  Roles of BN52021 in platelet-activating factor pathway in inflammatory MS1 cells.

Authors:  Shi-Hai Xia; Xiao-Hui Xiang; Kai Chen; Wei Xu
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.